China Ethylene Glycol Distearate (EGDS) Development Status and Investment Trend Forecast Report, 2026–2032

Table 42: Oleon’s latest corporate developments Table 43: Kao Corporation—Ethylene Glycol Distearate (EGDS) production bases, sales regions, competitors, and market position Table 44: Kao Corporation—Ethylene Glycol Distearate (EGDS) product specifications, parameters, and market applications Table 45: Kao Corporation—Ethylene Glycol Distearate (EGDS) sales volume (tons), revenue (US$ million), price (US$/ton), and gross margin (2022–2026) Table 46: Kao Corporation—Company profile and core business Table 47: Kao Corporation’s latest corporate developments Table 48: Glenn—Ethylene Glycol Distearate (EGDS) production bases, sales regions, competitors, and market position Table 49: Glenn—Ethylene Glycol Distearate (EGDS) product specifications, parameters, and market applications Table 50: Glenn—Ethylene Glycol Distearate (EGDS) sales volume (tons), revenue (US$ million), price (US$/ton), and gross margin (2022–2026) Table 51: Glenn—Company profile and core business Table 52: Glenn’s latest corporate developments Table 53: Nikko Chemicals—Ethylene Glycol Distearate (EGDS) production bases, sales regions, competitors, and market position Table 54: Nikko Chemicals—Ethylene Glycol Distearate (EGDS) product specifications, parameters, and market applications Table 55: Nikko Chemicals—Ethylene Glycol Distearate (EGDS) sales volume (tons), revenue (US$ million), price (US$/ton), and gross margin (2022–2026) Table 56: Nikko Chemicals—Company profile and core business Table 57: Nikko Chemicals’ latest corporate developments Table 58: Innospec—Ethylene Glycol Distearate (EGDS) production bases, sales regions, competitors, and market position Table 59: Innospec—Ethylene Glycol Distearate (EGDS) product specifications, parameters, and market applications Table 60: Innospec—Ethylene Glycol Distearate (EGDS) sales volume (tons), revenue (US$ million), price (US$/ton), and gross margin (2022–2026) Table 61: Innospec—Company profile and core business Table 62: Innospec’s latest corporate developments Table 63: Guoli Chemical—Ethylene Glycol Distearate (EGDS) production bases, sales regions, competitors, and market position Table 64: Guoli Chemical—Ethylene Glycol Distearate (EGDS) product specifications, parameters, and market applications Table 65: Guoli Chemical—Ethylene Glycol Distearate (EGDS) sales volume (tons), revenue (US$ million), price (US$/ton), and gross margin (2022–2026) Table 66: Guoli Chemical—Company profile and core business Table 67: Guoli Chemical’s latest corporate developments Table 68: Jiaxing Hudong Daily Chemical Additives—Ethylene Glycol Distearate (EGDS) production bases, sales regions, competitors, and market position Table 69: Jiaxing Hudong Daily Chemical Additives—Ethylene Glycol Distearate (EGDS) product specifications, parameters, and market applications

Global Low-Dose Hydrate Inhibitor Report: Market Size, Competitive Landscape of Leading Companies, and Industry Chain Analysis

12.6.5 Italmatch Chemicals—Latest corporate developments 12.7 Lamberti 12.7.1 Lamberti—Basic information, low-dose hydrate inhibitor production bases, sales regions, competitors, and market position 12.7.2 Lamberti—Low-dose hydrate inhibitor product models, specifications, parameters, and market applications 12.7.3 Lamberti—Low-dose hydrate inhibitor sales volume, revenue, price, and gross margin (2021–2026) 12.7.4 Lamberti—Company profile and core business 12.7.5 Lamberti—Latest corporate developments 12.8 Sterling Multi-Chem 12.8.1 Sterling Multi-Chem—Basic information, low-dose hydrate inhibitor production bases, sales regions, competitors, and market position 12.8.2 Sterling Multi-Chem—Low-dose hydrate inhibitor product models, specifications, parameters, and market applications 12.8.3 Sterling Multi-Chem—Low-dose hydrate inhibitor sales volume, revenue, price, and gross margin (2021–2026) 12.8.4 Sterling Multi-Chem—Company profile and core business 12.8.5 Sterling Multi-Chem—Latest corporate developments 12.9 Dosas 12.9.1 Dosas—Basic information, low-dose hydrate inhibitor production bases, sales regions, competitors, and market position 12.9.2 Dosas—Low-dose hydrate inhibitor product models, specifications, parameters, and market applications 12.9.3 Dosas—Low-dose hydrate inhibitor sales volume, revenue, price, and gross margin (2021–2026) 12.9.4 Dosas—Company profile and core business 12.9.5 Dosas—Latest corporate developments 12.10 Stepan 12.10.1 Stepan—Basic information, low-dose hydrate inhibitor production bases, sales regions, competitors, and market position 12.10.2 Stepan—Low-dose hydrate inhibitor product models, specifications, parameters, and market applications 12.10.3 Stepan—Low-dose hydrate inhibitor sales volume, revenue, price, and gross margin (2021–2026) 12.10.4 Stepan—Company profile and core business 12.10.5 Stepan—Latest corporate developments 12.11 Innospec 12.11.1 Innospec—Basic information, low-dose hydrate inhibitor production bases, sales regions, competitors, and market position 12.11.2 Innospec—Low-dose hydrate inhibitor product models, specifications, parameters, and market applications 12.11.3 Innospec—Low-dose hydrate inhibitor sales volume, revenue, price, and gross margin (2021–2026)

Innospec Projects 2027 Free Cash Flow of $55 Million to $60 Million

5 days ago

Innospec projects 2027 free cash flow of $55–60 million, contingent on stable raw-material costs and North Carolina plant upgrades. Q3 2026 revenue increased 7% year-over-year to $473.6 million.

www.tokenpost.com

2026-04-02

Tudor Investment Corp Lowers Holdings in Innospec Inc.

2026-04-04

Innospec Inc. Reports Q4 2025 Earnings with $455.6M Revenue

2026-04-05

Innospec Schedules First Quarter 2026 Earnings Release and Conference Call

2026-04-07

Barentz Inks Distribution Agreement with Innospec in Canada

2026-04-07

Innospec Schedules First Quarter 2026 Earnings Release and Conference Call